YesAbstract: Background: Medicines are often suboptimally managed for heart failure patients across the transition from hospital to home, potentially leading to poor patient outcomes. The Improving the Safety and Continuity Of Medicines management at Transitions of care programme included: understanding the problems faced by patients and healthcare professionals; developing and co-designing the Medicines at Transitions of care Intervention (MaTI); a cluster randomized controlled trial testing the effectiveness of a complex behavioural MaTI aimed at improving medicines management at the interface between hospitals discharge and community care for patients with heart failure; and a process evaluation. The MaTI included a patient-held My Med...
YesIntroduction: There are risks to the safety of medicines management when patient care is transfer...
Introduction: Poor medicines management places patients at risk, particularly during care transition...
Heart failure is a chronic disease that increases mortality, reduces quality of life, and increases ...
YesAbstract: Background: Medicines are often suboptimally managed for heart failure patients acros...
YesMedicines are often suboptimally managed for heart failure patients across the transition from ho...
Background Medicines are often suboptimally managed for heart failure patients across the transitio...
YesIntroduction Heart failure affects 26 million people globally, approximately 900 thousand people ...
Introduction A key priority for the UK National Health Service and patients is to ensure that medici...
YesHeart failure affects 26 million people globally, and the optimal management of medicines is cruc...
NoAvoidable harm associated with medicines is widespread – particularly at care transitions – and un...
OBJECTIVE: To test whether a drug review and symptom self management and lifestyle advice interventi...
Objective: The objective of this study is to determine if a model for patient-centered care that int...
Background:: Pharmacists may assist with reducing 30-day readmission rates for patients with heart f...
Background: Heart failure (HF) is common, disabling and deadly. Patients with HF often have poor sel...
Background Medication misadventure is greatest at times of change such as the transition from hospit...
YesIntroduction: There are risks to the safety of medicines management when patient care is transfer...
Introduction: Poor medicines management places patients at risk, particularly during care transition...
Heart failure is a chronic disease that increases mortality, reduces quality of life, and increases ...
YesAbstract: Background: Medicines are often suboptimally managed for heart failure patients acros...
YesMedicines are often suboptimally managed for heart failure patients across the transition from ho...
Background Medicines are often suboptimally managed for heart failure patients across the transitio...
YesIntroduction Heart failure affects 26 million people globally, approximately 900 thousand people ...
Introduction A key priority for the UK National Health Service and patients is to ensure that medici...
YesHeart failure affects 26 million people globally, and the optimal management of medicines is cruc...
NoAvoidable harm associated with medicines is widespread – particularly at care transitions – and un...
OBJECTIVE: To test whether a drug review and symptom self management and lifestyle advice interventi...
Objective: The objective of this study is to determine if a model for patient-centered care that int...
Background:: Pharmacists may assist with reducing 30-day readmission rates for patients with heart f...
Background: Heart failure (HF) is common, disabling and deadly. Patients with HF often have poor sel...
Background Medication misadventure is greatest at times of change such as the transition from hospit...
YesIntroduction: There are risks to the safety of medicines management when patient care is transfer...
Introduction: Poor medicines management places patients at risk, particularly during care transition...
Heart failure is a chronic disease that increases mortality, reduces quality of life, and increases ...